MedTrace Logo

Celect Vena Cava Filter Clinical Trial

NCT00470626 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2016-01-25

Study results available
· View outcomes & findings →

Summary

The clinical study will collect data to verify the safety and performance of the Cook Celect Filter in the prevention of pulmonary embolism (PE) in patients with a temporary or permanent high risk of thromboembolism.

Conditions

Interventions

DEVICE

Celect Vena Cava Filter

Effective filtration of inferior vena cava blood to prevent thromboembolism.

Sponsors & Collaborators

  • MED Institute, Incorporated

    collaborator INDUSTRY

  • William Cook Australia

    collaborator INDUSTRY

  • William Cook Europe

    collaborator INDUSTRY

  • Cook Ireland, Ltd.

    collaborator INDUSTRY

  • Cook Group Incorporated

    lead INDUSTRY

Principal Investigators

  • R.W. Gunther, Prof. · Klinik Fur Radiologische Diagnostik Universitaetklinikum der RWTH Aachen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • Australia
  • Germany
  • Mexico
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00470626 on ClinicalTrials.gov